Healthy adults
Conditions
Interventions
Take 2000mg capsule containing magnesium derived from rice bran (containing 300mg of magnesium) one time.
Take 1746mg capsule containing magnesium phosphate, tribasic (containing 300mg of magnesium) o
Sponsors
Tsuno Rice Fine Chemicals Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy individuals in their 20s to 40s. 2. Healthy individuals without chronic physical illnesses, as confirmed through medical interviews. 3. Individuals not consuming any food products with fatigue-recovery effects. 4. Individuals who have received sufficient explanation regarding the purpose and content of this trial, possess the capacity to consent, voluntarily volunteer to participate after fully understanding the details, and can provide written consent to participate in this trial. 5. Individuals who can attend the designated examination date and undergo the examination. 6. Individuals deemed suitable for participation in this trial by the principal investigator.
Exclusion criteria
Exclusion criteria: 1. Individuals currently suffering from any disease and undergoing drug therapy. 2. Individuals with severe disease symptoms such as motor dysfunction or respiratory disorders. 3. Individuals unable to refrain from taking over-the-counter magnesium supplements during the trial period. 4. Individuals with allergies (to pharmaceuticals or trial-related products). 5. Individuals who are pregnant, breastfeeding, or intend to become pregnant during the trial period. 6. Individuals who currently have, or have had within the past month, a habit of continuously taking or applying medications specifically marketed for magnesium fortification or supplementation. 7. Individuals using potent pharmaceuticals (as determined by the principal investigator). 8. Other individuals deemed unsuitable for this trial by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma magnesium concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-Consumption Health Questionnaire | — |
Countries
Japan
Contacts
Public ContactYuki Inoue
Tsuno Rice Fine Chemicals Co., Ltd. Section II. Planning and Deveropment Dept 3. Research and Development Div.
Outcome results
None listed